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SUMMARY
We investigated the role of autophagy in atherosclerosis. During plaque formation in mice,
autophagic markers co-localized predominantly with macrophages (mϕ). Atherosclerotic aortas
had elevated levels of p62, suggesting that dysfunctional autophagy is characteristic of plaques. To
determine if autophagy directly influences atherogenesis, we characterized Beclin-1 heterozygous-
null and mϕ-specific ATG5-null (ATG5-mϕKO) mice, commonly used models of autophagy
haploinsufficiency and deficiency, respectively. Haploinsufficent Beclin-1 mice had no
atherosclerotic phenotype, but ATG5-mϕKO mice had increased plaques suggesting an essential
role for basal levels of autophagy in atheroprotection. Defective autophagy is associated with pro-
atherogenic inflammasome activation. Classic inflammasome markers were robustly induced in
ATG5-null mϕ, especially when co-incubated with cholesterol crystals. Moreover, cholesterol
crystals appear to be increased in ATG5-mϕKO plaques, suggesting a potentially vicious cycle of
crystal formation and inflammasome activation in autophagy-deficient plaques. These results
show that autophagy becomes dysfunctional in atherosclerosis and its deficiency promotes
atherosclerosis in part through inflammasome hyperactivation.
INTRODUCTION
Autophagy is the mechanism by which cytoplasmic components such as organelles and
protein aggregates are broken down and recycled via the lysosomal apparatus (reviewed in
(Kundu and Thompson, 2008)). During periods of starvation, autophagy promotes survival
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by degrading the cytoplasm in bulk, whereas during nutrient excess, autophagy acts to
selectively remove damaged organelles (Klionsky and Emr, 2000; Kundu and Thompson,
2008). This process is highly evolutionarily conserved, but mammalian organisms have also
adapted autophagy for more diverse uses such as clearance of pathogens and coordination
with apoptosis (Levine et al., 2011; Maiuri et al., 2007). Autophagy is relevant to human
disease. Defects in autophagy have been implicated in the pathogenesis of cancers,
neurodegenerative diseases, heart failure, and inflammatory bowel disease (Komatsu et al.,
2006; Kundu and Thompson, 2008; Levine and Kroemer, 2008; Levine et al., 2011; Nakai et
al., 2007). Little is known about the role of autophagy in atherosclerosis.
Limited evidence indicates that autophagy occurs in atherosclerosis, an expected finding
given the presence of autophagic markers in most organ systems. Transmission electron
microscopy images of atherosclerotic plaques reveals structures consistent with
autophagosomes (Kockx et al., 1998; Martinet and De Meyer, 2009) and certain marker
proteins of autophagy have been detected in atherosclerotic plaques by immunoblot or
immunohistochemical analysis (Martinet et al., 2004; Martinet and De Meyer, 2009). The
degree to which autophagy occurs in plaque development, which cells in the atheroma
contribute to this process, and whether autophagy impacts lesion formation are unknown.
Here, we address these issues using animals with experimental atherosclerosis, ApoE-null
mice. We found that while most cells of the plaque have autophagic markers, macrophages
appear to be most active at this process, and that autophagy becomes dysfunctional with
plaque progression. We show that complete disruption of macrophage autophagy, but not
partial disruption, increases plaque formation. Mechanistically, this process in part involves
hyperactivation of the macrophage inflammasome and excess IL-1β production. In the
autophagy-deficient setting, cholesterol crystals, a hallmark of atherosclerotic plaques,
become potent stimuli for inflammasome activation.
RESULTS
Progressive Atherosclerosis Has Features of Dysfunctional Autophagy
Autophagy is dynamic with autophagosome formation, cargo sequestration, and eventual
lysosomal fusion/degradation occurring in rapid succession. Not surprisingly, there are no
ideal techniques for assessing autophagy flux in vivo (Klionsky et al., 2008). However, p62/
SQSTM1, a chaperone that shuttles intracellular protein aggregates into autophagosomes for
degradation, has emerged as a useful marker of autophagic status (Bjorkoy et al., 2005;
Klionsky et al., 2008; Komatsu et al., 2007; Mathew et al., 2009). Since the entire p62/
SQSTM1-protein aggregate complex is degraded after engulfment by the autolysosome,
p62/SQSTM1 levels are inversely correlated with autophagic flux, i.e. increases in p62/
SQSTM1 indicate defective autophagy (Komatsu et al., 2007; Mathew et al., 2009). We fed
ApoE-null mice (known to be atherosclerosis susceptible) and their wild type counterparts
(with normal ApoE alleles, no defects in cholesterol metabolism, and thus atherosclerosis
resistant) a Western diet for 2 months and assessed p62 levels in aortic lysates. p62 protein
was dramatically increased in atherosclerotic aortas (Figure 1A), consistent with the
presence of defective autophagy. Levels of p62 mRNA were not significantly increased in
atherosclerotic aortas and prolonged fasting (a known stimulus for induction of autophagy)
of these mice resulted in decreased levels of p62 protein in atherosclerotic aortas (data not
shown), suggesting that changes in aortic p62 protein reflect in vivo autophagy status. To
determine how plaque progression affects autophagy, we prepared aortic lysates from ApoE-
null mice over time since atherosclerosis progresses with age in this model. p62 levels rise
with increasing age/plaque burden (Figure 1B). Protein levels of Beclin-1, a component of
the complex involved in initial nucleation/formation of the autophagosome (Levine and
Kroemer, 2008), were not significantly different in these lysates (Figure 1A,B), suggesting
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that any observed autophagy effects in atherosclerosis might involve downstream
components of the autophagic pathway.
To determine which cells in atherosclerotic plaques express autophagy markers, we
characterized ApoE-null atherosclerotic aortic roots by immunofluorescence. The autophagy
markers p62 (Figure 1C) and LC3/ATG8 (Figure 1D) were concurrently imaged with
MOMA-2 (an antibody that recognizes monocyte-macrophages), an antibody to CD11b
(expressed predominantly on monocyte-macrophages), an antibody to α-smooth muscle cell
actin (specific for smooth muscle cells), or an antibody directed to the pan-leukocyte marker
CD45. Both p62 and LC3/ATG8 co-localize with plaque leukocytes (Figure 1C, D lower
right panels) that are mostly of the monocyte-macrophage macrophage lineage, i.e.
MOMA-2 or CD11b positive cells (Figure 1C, D left panels). Smooth muscle cells
constitute a small portion of these early atherosclerotic lesions and do not appear to
contribute significantly to the autophagic process (Figure 1C, D upper right panels). These
results suggest that monocyte/macrophages are the predominant cell type expressing
autophagy markers in the plaque and are likely responsible for progressive autophagy
deficiency.
Autophagy Haploinsufficiency Has No Effect on Plaque Progression
To perturb autophagy in atherosclerosis, we first used Beclin-1/ATG6 heterozygous-
deficient (also known as Beclin-Het) mice. These animals are haploinsufficient for
autophagy in numerous organ systems and have been used to assess the function of
autophagy in cancer and heart failure (Qu et al., 2003; Yue et al., 2003; Zhu et al., 2007).
Beclin-Het mice and their control counterparts each on the ApoE-null background were fed
a Western diet for two months. Protein levels of p62 were increased in aortic lysates from
Beclin-Hets confirming deficiency in plaque autophagy (Figure 2A). There was no
genotype-specific effect on body weight, serum lipids, or insulin sensitivity as gauged by
glucose and insulin tolerance tests (Supplemental Figure 1A,B,C). Surprisingly, the presence
of a partial autophagy defect in the Beclin-Het/ApoE null animals did not affect the extent of
atherosclerosis assayed at the aortic root (Figure 2B) or in the whole aorta en face (Figure
2C) as compared to ApoE null animals that were wild type at the Beclin locus.
Complete Deficiency of Macrophage Autophagy Is Pro-inflammatory
One interpretation of the lack of effect of Beclin haploinsufficency on atherosclerosis is that
the autophagy defect in this model is inadequate to impact atheroma progression. To pursue
this notion, we compared macrophages from Beclin-Het mice with those from macrophage-
specific ATG5-null (ATG5-mϕKO) mice, cells with complete absence of an autophagy
gene. ATG5-null mϕ in vitro had the expected absence of ATG5 in concert with dramatic
increases in p62 levels and a loss of the lipidated-LC3 band, both characteristic of complete
autophagy deficiency (Figure 3A).
The significant degree of autophagy deficiency in ATG5-null mϕ also manifested itself
functionally. After stimulation with LPS, ATG5-null macrophages selectively secreted
IL-1β, but not TNF-α, at levels considerably greater than control macrophages (Figure 3B).
In contrast, Beclin-Het macrophages failed to secrete either cytokine at levels different from
control macrophages (Figure 3C). This in vitro pro-inflammatory phenotype was
recapitulated in vivo since macrophage-specific ATG5-null mice (ATG5-mϕKO) robustly
produced serum IL-1β in response to LPS injection (Figure 3D). Even in the absence of LPS
stimulation, serum IL-1β levels were increased in ATG5-mϕKO/ApoE-null mice fed a
Western diet for two months as compared to similarly treated ApoE null mice with normal
levels of macrophage ATG5 (Figure 3E). Other classic pro-inflammatory (TNFα) and anti-
inflammatory (IL-10) cytokines were not altered in the serum (Supplemental Figure 2),
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suggesting that ATG5 deficiency promotes a specific pro-inflammatory state with metabolic
stress. ATG16L1-null macrophages, another model of autophagy deficiency, also selectively
hypersecrete IL-1β in response to LPS (Saitoh et al., 2008).
Complete Deficiency of Macrophage Autophagy Enhances Plaque Progression
To determine if the absence of macrophage autophagy affects atherosclerosis, we fed a
Western diet for two months to ATG5-mϕKO mice and control mice carrying ATG5 floxed
alleles in the absence of the Cre transgene each on an ApoE-null background. p62 levels
were increased in the vasculature of the ATG5-mϕKO animals consistent with deficient
plaque autophagy (Figure 4A). There was no genotype-specific effect on body weight,
serum lipids, or insulin sensitivity (Supplemental Figure 3A,B,C). However, atherosclerotic
lesions were increased in ATG5-mϕKO compared to controls as assayed by both aortic root
and whole aorta en face techniques (Figure 4B,C).
The increased Oil Red O staining seen in ATG5-mϕKO lesions (Figure 4B) suggested an
increase in foam cells, usually of macrophage origin. Indeed, staining aortic roots with
MOMA-2 revealed a significant portion of the ATG5-mϕKO plaque area is composed of
macrophages (data not shown). These observations are supported by a recent report
demonstrating a role for autophagy in cholesterol efflux and foam cell formation (Ouimet et
al., 2011). In this regard, we also observed a reduced capacity for cholesterol efflux in
ATG5-mϕKO macrophages (Figure 4D). Given the pro-inflammatory phenotype of ATG5-
mϕKO macrophages, we also assessed the degree of IL-1β in atherosclerotic aortas from
control and ATG5-mϕKO animals. After two months of Western diet feeding, a pro-
atherogenic intervention leading to overt plaque formation, IL-1β levels were markedly
elevated in ATG5-mϕKO aortas (Figure 4E). In contrast, with chow diet feeding, a condition
under which atherogenesis is blunted, IL-1β levels were not significantly altered (Figure
4F). Moreover, aortic p62 levels were not significantly elevated on a chow diet (Figure 4G),
supporting the notion that autophagy deficiency in plaques is associated with progressive
macrophage infiltration and atherogenesis.
Autophagy Deficiency Leads to Hyperactivation of the Macrophage Inflammasome
To understand the mechanistic basis of increased atherosclerosis in ATG5-mϕKO mice, we
returned to the pro-inflammatory phenotype of the macrophages in these animals. The
hypersecretion of IL-1β in response to LPS (Figure 3B) by ATG5-null macrophages does
not occur due to transcriptional effects since message levels for IL-1β and TNF-α respond
similarly to LPS in ATG5-null and control macrophages (Supplemental Figure 4). IL-1β
protein is processed from a precursor form to a mature, secreted form through activation of
caspase-1, the major effector of inflammasome action (Davis et al., 2011; Schroder et al.,
2010). Thus, selective hypersecretion of IL-1β is characteristic of inflammasome activation.
Similar levels of pro-IL-1β were present in cell lysates from both ATG5-null and control
macrophages after LPS treatment (Figure 5A, upper panels), but ATG5-null macrophages
hypersecrete the active/truncated forms of both IL-1β and the caspase-1 p10 subunit (Figure
5A, lower panels). Therefore, defects in autophagy due to ATG5 deficiency produce
inflammasome hyperactivation resembling findings with defects in autophagy due to
ATG16L1 deficiency (Saitoh et al., 2008).
Inflammasome activation may be critical for atheroma progression, various forms of
crystalline/particulate materials are potent stimuli for inflammasome activation, and recent
findings indicate that cholesterol crystals, a hallmark of atherosclerotic plaques, trigger this
process (Duewell et al., 2010; Rajamaki et al., 2010). Treatment of ATG5-null macrophages
with a combination of LPS and cholesterol crystals induced IL-1β secretion to levels
several-fold higher than LPS alone (Figure 5B). Cholesterol crystal addition did not affect
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the phenotypic appearance of macrophages in these experiments (not shown). To confirm
that such robust secretion of IL-1β in the setting of autophagy deficiency was primarily an
inflammasome-dependent process, we conducted a series of complementary experiments.
Although LPS increases the transcription of certain components of the inflammasome, the
transcriptional response is not altered in the setting of autophagy deficiency (Supplemental
Figure 5). Stimulation of ATG5-null macrophages with LPS and cholesterol crystals leads to
increased formation of Apoptotic Speck Protein bodies (ASC “specks”) (Figure 5C), a
hallmark of inflammasome complex formation and activation (Huang et al., 2009).
Macrophages from macrophage-specific ATG7-null mice, an independent model of
autophagy-deficiency have similarly elevated IL-1β responses to LPS and cholesterol
crystals (Figure 5D). Chemical inhibition of Caspase-1, the downstream effector of
inflammasome activation, blunts IL-1β responses in macrophages (Figure 5E). Similarly,
macrophages lacking either NLRP3 or ASC, the primary components of the inflammasome
complex, have a highly diminished capacity to secrete IL-1β (Figure 5F).
Conversely, although induction of autophagy has been reported to reduce IL-1β (Harris et
al., 2011), this effect appears to be independent of inflammasomes since induction of
autophagy in macrophages through nutrient depletion decreases cellular levels of both pro-
and mature forms of IL-1β in concert with reducing its secretion (Supplemental Figure 6).
This result, using peritoneal macrophages and confirming the findings of Harris et al.
(2011), was limited to induction of autophagy. In a different model system, bone marrow-
derived macrophages, induction of autophagy in combination with the NLRP3 agonist
nigericin promotes the unconventional secretion of IL-1β (Dupont et al., 2011). These data
suggest that the effects of temporally discrete induction of autophagy on IL-1β responses are
complex and context-dependent. However, our results indicate that defective basal
autophagy in mice with ATG5-null macrophages increases atherosclerosis and aortic IL-1β
levels in a manner that appears to involve the inflammasome.
Potential Mediators of Atherosclerotic Progression
Cholesterol crystals are a significant component of atherosclerotic plaques and are also
detectable in early lesions (Duewell et al., 2010). Cholesterol crystal area as determined by
reflectance microscopy was increased in ATG5-mϕKO atherosclerotic lesions (Figure 6A).
One interpretation of this finding is that the pro-inflammatory state of ATG5-null
macrophages may be perpetuated by the increased cholesterol crystal burden of
atherosclerotic plaques. Extracellular cholesterol crystals are initially trafficked to the
lysosomal compartment of the macrophage where they are inefficiently and partially
dissolved for downstream reesterification (Duewell et al., 2010; Kruth et al., 1995; Rajamaki
et al., 2010). Persistently undissolved crystals remain trapped in the lysosomal compartment
where they may render the lysosome and processes such as autophagy dysfunctional
(Duewell et al., 2010; Rajamaki et al., 2010). Indeed, macrophages incubated with
cholesterol crystals over a 12 hour period show concomitant increases in p62 levels and
increased conversion of LC3-I to LC3-II, suggesting that although some components of the
autophagic process are not affected, the final fusion/degradation step with the lysosome is
impaired (Figure 6B). Thus, cholesterol crystals have the ability to incite inflammasome
activation as well as block autophagic processing.
One of the proposed mechanisms for inflammasome activation has been the presence of
reactive oxygen species (ROS) (Gross et al., 2011; Naik and Dixit, 2011). Thus, we looked
for signatures of ROS activation in the ATG5-mϕKO atherosclerotic plaques. Protein
carbonylation, a marker of increased oxidative modification of proteins (Stadtman, 1993),
was significantly elevated in atherosclerotic ATG5-mϕKO aortas as assessed by Western
blot analysis (Figure 6C). Similarly, dihydroethidium (DHE) staining of atherosclerotic
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aortic roots, a measure of intracellular superoxide levels, was increased in ATG5-mϕKO
plaques (Figure 6D).
DISCUSSION
In this study, we provide evidence supporting a role for defective autophagy in the
pathogenesis of atherosclerosis. Progressive plaque formation has features of defective
autophagy predominantly related to plaque macrophages. A modest decrease in plaque
autophagy (Beclin-Het model) does not affect experimental atherosclerosis but the loss of
macrophage autophagy (ATG5-mϕKO model) accelerates atheroma progression. The
autophagy-deficient setting appears to exacerbate a cholesterol crystal-mediated
hyperactivation of the macrophage inflammasome with its pro-atherogenic IL-1β response.
Links between autophagy, the inflammasome, and atherogenesis are summarized in Figure
7.
Atherosclerosis is complex and our understanding of the biology of proteins such as ATG5
is evolving. It is possible that autophagy-independent roles of ATG5 might be involved in
the atherosclerotic phenotype of the ATG5-mϕKO mice. However, inflammasomes are
involved in atherosclerosis (Duewell et al., 2010), IL-1β secretion may indicate
inflammasome activation (Davis et al., 2011), and deficiencies of three distinct autophagy
proteins--ATG16L1 (Saitoh et al., 2008), ATG5 (Figure 5B) and ATG7 (Figure 5D), are
associated with increased IL-1β secretion. Collectively, these findings support the notion
that autophagy deficiency promotes atherosclerosis.
Cholesterol crystals, characteristic of atherosclerotic plaques, activate inflammasomes,
providing a mechanistic basis for propagating atherogenesis (Duewell et al., 2010; Masters
et al., 2011). Our results indicate that intact autophagy suppresses the inflammasome, but the
nature of this suppression is unclear. One potential mechanism could involve the autophagic
removal of damaged mitochondria (also called mitophagy), in turn reducing reactive oxygen
species (ROS) production. Release of ROS and DNA from damaged mitochondria can
activate inflammasomes, a process that is exacerbated in the absence of mitophagy (Naik
and Dixit, 2011; Nakahira et al.; Zhou et al., 2011). The observation that ATG5-mϕKO
plaques have increased markers of protein oxidation and superoxide production lends
credence to this possibility. Also consistent with this notion, the saturated fatty acid
palmitate appears to inhibit autophagy while also increasing mitochondrial ROS to induce
inflammasome activation (Wen et al., 2011).
A second potential mechanism could involve the removal of dysfunctional lysosomes (so-
called lysosomophagy) (Klionsky et al., 2007). Lysosomal destabilization, which promotes
inflammasome activation, has been reported when poorly digestible extracellular particulate
matter (including cholesterol crystals) is phagocytosed and shuttled to lysosomes for
degradation (Duewell et al., 2010; Hornung et al., 2008; Masters et al., 2011). The pro-
inflammatory nature of these dysfunctional lysosomes can be accentuated in the absence of
lysosomophagy. Additionally, evidence that cholesterol crystals affect the progression of
autophagy at the level of the lysosome serves to further exacerbate this process. Given the
broad range of organelles and cellular components cleared by autophagy, pleiotropic
mechanisms may be coordinately activating the inflammasome in the setting of defective
autophagy.
What degree of autophagy-deficiency is pro-atherogenic? The difference in phenotypes
between the Beclin-Het and ATG5-mϕKO mice suggests that promotion of atherosclerosis
requires considerable disruption of constitutive plaque autophagy. However, autophagy
deficient states in humans would be expected to be incompatible with life: all animal models
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of whole-body autophagy deficiencies described to date are either embryonically or
neonatally lethal (Komatsu et al., 2005; Kuma et al., 2004; Saitoh et al., 2008). If, as
suggested by our results with Beclin-Het animals, autophagy heterozygosity in humans is
not pro-atherogenic, severe defects in autophagy would have to be acquired in order to
impact human vascular disease.
Published evidence supports this possibility. Cells in atherosclerotic plaques develop
progressive lysosomal dysfunction with features resembling a lysosomal storage disease
(Jerome, 2006). The accumulation of unhydrolyzed cholesteryl esters and trapped/poorly
translocated free cholesterol in lysosomes has been described in macrophage foam cells
(Brown et al., 2000; Dhaliwal and Steinbrecher, 2000; Griffin et al., 2005; Jessup et al.,
1992; Lougheed et al., 1991; Yancey and Jerome, 2001). These unmetabolized substituents
may impair the lysosomal degradation capacity of lipases as well as other enzymes including
proteases. Our observation that p62 accumulates in advanced atherosclerotic plaques is
consistent with this concept.
If acquired defects in plaque autophagy exacerbate atherosclerosis, inducing autophagy
might be anti-atherogenic. No studies have addressed this notion directly. However,
sirolimus and everolimus, both inhibitors of the autophagy-suppressing kinase mTOR and
thus classic stimulators of autophagy, are anti-atherogenic in mice (Castro et al., 2004;
Mueller et al., 2008; Pakala et al., 2005; Zhao et al., 2009). Calorie-restricted mice, another
stimulus for autophagy induction (Wohlgemuth et al., 2007), also have reduced
atherosclerosis (Guo et al., 2002).
Atherosclerosis has been documented in humans who lived ~1500 BCE (Allam et al., 2009),
when epidemic obesity and highly processed, nutrient-dense foods did not exist. Egyptian
scholars attributed vascular disease to “wekhedu”, undigested food that accumulated in the
vasculature to limit blood flow and promote disease. Since deficient autophagy reflects an




Protocols were approved by the Washington University Animal Studies Committee. Beclin
+/− (Beclin-Het) mice, a gift from Dr. Nathaniel Heintz, Rockefeller University (Yue et al.,
2003), were backcrossed with ApoE−/− mice (C57BL/6 background) to generate Beclin+/
−ApoE null and Beclin+/+ApoE null littermates used for experiments that were >N7
C57BL/6. Mice with the floxed ATG5 locus, a gift from Dr. Noboru Mizushima, Tokyo
Medical & Dental University (Hara et al., 2006), were crossed with Cre-recombinase
transgenic mice under the control of the Lysosomal-M promoter and ApoE−/− mice to
generate mice with macrophage-specific ATG5 deficiency and littermate controls that were
>N7 C57BL/6. Beclin, ATG5, Cre, and ApoE genotyping was performed as previously
described (Chakravarthy et al., 2005; Hara et al., 2006; Yue et al., 2003). ATG7flox/flox,
NLRP3−/−, and ASC−/− mice have been previously described (Hara et al., 2006;
Mariathasan et al., 2004; Sutterwala et al., 2006). Mice housed in a specific pathogen-free
barrier facility were weaned at 3 weeks of age to a standard mouse chow providing 6%
calories as fat, then started on a Western-type diet containing 0.15% cholesterol providing
42% calories as fat (TD 88137, Harlan, Madison, WI) at ~8 weeks of age.
Analytical Procedures and Lesion Quantification
Serum IL-1β, whole aorta IL-1β, and secreted IL-1β and TNF-α from culture media were
measured using ELISA assays from R&D Systems Inc (MLB00B) and BD Biosciences
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Pharmingen (559732). Cholesterol, triglycerides, glucose and free (nonesterified) fatty acids
(FFA) were assayed in serum following a 4-hour fast as described (Li et al., 2000). Glucose
tolerance and insulin tolerance tests (GTT and ITT) were separated by at least a week using
fasted mice that were injected with 10% D-glucose (1 g/kg) or human regular insulin (0.75
units/kg body weight, Eli Lilly and Co., Indianapolis, IN). Tail vein blood for these tests was
assayed at 0, 30, 60, and 120 min using a glucose meter (Contour, Bayer Healthcare,
Mishawaka, IN). Serum TNF-α and IL-10 were measured using ELISA assays from BD
Biosciences Pharmingen (559732) and R&D Systems Inc (M1000). For assessment of
IL-1β, TNFα, NLRP3, ASC, and Caspase-1 transcript levels, extraction of total RNA,
reverse transcription, and quantitative RT-PCR were performed as described (Razani et al.,
2011). Sequences for the oligonucleotide primers used were designed using the
qPrimerDepot database-http://primerdepot.nci.nih.gov. Assays were performed in duplicate
and normalized to amplified mRNA for ribosomal protein L32.
The en face and aortic root cross-section techniques previously described (Semenkovich et
al., 1998) were used to quantify atherosclerosis throughout the aorta as well as at the vessel
origin. En face regions were analyzed as the aortic arch (from the aortic valve to the left
subclavian artery), thoracic aorta (from the left subclavian artery to the final intercostal
arteries), and abdominal aorta (from the intercostal arteries to the bifurcation of the iliac
arteries).
Macrophage Culture and Inflammasome Stimulation
Macrophages were isolated essentially as described (Febbraio et al., 2000) by injecting mice
intraperitoneally with a 4% solution of thioglycollate media (Sigma, St. Louis, MO) on day
1. On day 5, peritoneal macrophages were isolated, washed, counted, and plated in DMEM
with 10% FBS. Macrophages were subsequently harvested at various times to isolate protein
using standard techniques. Cholesterol crystals were generated by subjecting cholesterol
powder (Sigma, St. Louis, MO) to an ethanol precipitation technique as described (Rajamaki
et al., 2010; Whiting and Watts, 1983). Time-course stimulation with LPS (Sigma, St. Louis,
MO) with or without cholesterol crystals was performed as indicated in the respective figure
legends. Chemical inhibition of inflammasomes was performed with 10 mM Caspase-1
inhibitor Z-YVAD-FMK (Enzo Life Sciences, Farmingdale, NY).
Cholesterol Efflux
Experiments were performed as described with some modifications (Schneider et al., 2010).
Briefly, 3H-labeled AcLDL was made by incubating AcLDL (Invitrogen - 100 µg/ml)
with 3H-cholesterol (American Radiolabel Chemical - 2.5 µCi/ml) for 24 hours.
Macrophages were labeled with 3H-labeled AcLDL for 24 hours, equilibrated in 0.2% BSA
for 12 hours, and incubated in the presence or absence of ApoAI (Invitrogen - 25 µg/ml) for
an 8, 24, and 48 hour time-course. The ApoAI-dependent cholesterol efflux was determined
as a percentage of 3H-cholesterol in the media relative to total 3H-cholesterol in the media
and cells.
Western Blotting
Separation, transfer and blotting were performed as described (Razani et al., 2001) using the
following antibodies: p62/SQSTM1 (610832) from BD Biosciences, San Diego, CA; β-actin
(A2066) from Sigma-Aldrich Corp., St. Louis, MO; Beclin-1 (H-300) and Caspase-1 p10
(M-20) from Santa Cruz Biotechnology Inc., Santa Cruz, CA; LC3/ATG8 (NB100-2220)
and ATG5 (NB110-53818) from Novus Biologicals Inc., Littleton, CO; and IL-1β (AF-401-
NA) from R&D Systems Inc., Minneapolis, MN. Detection of protein oxidation by Western
blotting was performed using the OxyBlot™ Kit (Millipore, Billerica, MA) per
manufacturer’s instructions.
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Immunofluorescence microscopy of frozen-tissue sections and paraformaldehyde-fixed
macrophages was performed as previously described (Razani et al., 2001). Studies included
parallel experiments omitting primary or secondary antibodies to validate specificity of the
images. The following primary antibodies were used: p62/SQSTM1 (GP62) from Progen
Biotechnik BmbH, Heidelberg, Germany; LC3/ATG8 (#2775) from Cell Signaling
Technology Inc., Danvers, MA; MOMA-2 (MCA519G) from AbD Serotec, Oxford, UK; α-
smooth muscle actin (1A4 – FITC conjugate) from Sigma-Aldrich Corp., St. Louis, MO;
CD11b (14-0112) and CD45 (14-0451) from eBioscience Inc., San Diego, CA; and ASC
(AL177) from Enzo Life Sciences, Inc., Plymouth Meeting, PA. Species-specific
fluoroprobe-conjugated secondary antibodies were obtained from Invitrogen Corp.,
Carlsbad, CA. Imaging of cholesterol crystals was performed using reflectance microscopy
(Zeiss LSM 510 confocal laser-scanning microscope) essentially as previously described
(Duewell et al., 2010). Crystal area quantification was performed with ImageJ software
(imagej.nih.gov). Assessment of oxidative stress in aortic root frozen-tissue sections was
performed by fluorescence microscopy of dihydroethidium (DHE) stained sections as
previously described (Michel et al., 2011).
Statistical Analyses
Statistical significance of differences was calculated using the Student unpaired t test for
parametric data (in vitro macrophage experiments and serum metabolites; GTT and ITT
results) or the Mann-Whitney test for nonparametric data (atherosclerosis and cholesterol
crystal quantitation). Graphs containing error bars show the mean ± standard error of the
mean (SEM).
HIGHLIGHTS
• Atherosclerotic plaques have features of defective mϕ autophagy
• Complete deficiency of mϕ autophagy increases atherosclerosis
• Loss of mϕ autophagy leads to hyperactivation of inflammasomes and IL-1β
release
• Cholesterol crystals exacerbate inflammasome activation in autophagy
deficiency
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Assessment of Autophagy in the Atherosclerotic Plaque
(A, B) Western blot analysis of p62 and Beclin-1 in whole aorta lysates from (A) wild type
(WT, n=4) and ApoE-null (n=5) mice fed a Western diet for 2 months, and (B) ApoE-null
mice of increasing age (10 to 60 weeks). Densitometric quantification is shown below each
respective Western blot. Data are presented as mean ± SEM. *P<0.05, NS = not significant.
(C, D) Immunofluorescence microscopy of aortic root frozen sections from an ApoE-null
mouse fed a Western diet for 2 months. (C) In all quadrants, p62 stains (red) and
Hoechst-33258 nuclear stains (purple) are shown. Green stains are as follows: MOMA-2
(left upper panel), CD11b (left lower panel), αSMC-Actin (right upper panel), and CD45
(right lower panel). (D) Similar stains to (B) except LC3/ATG8 staining (red) instead of
p62. For all panels, smaller individual stains for each protein (labeled) are shown on the left
and a larger merged image is shown on the right.
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Figure 2. Quantification of Atherosclerosis in the Beclin-Het Autophagy-Deficient Model
(A) Western blot analysis of Beclin-1, p62, and β-actin in whole aorta lysates from control
(n=3) and Beclin-Het (n=3) mice each on an ApoE-null background fed a Western diet for 2
months. Densitometric quantification is shown to the right. Data are presented as mean ±
SEM. *P<0.05.
(B, C) Cohorts of control and Beclin-Het mice (# of mice shown) were placed on a Western
diet for 2 months and atherosclerotic area involvement was determined by computer image
analyses.
(B) Oil Red O-stained sections of aortic roots (representative aortic root sections are shown
on the right). (C) En face results for the total aorta and its regions (aortic arch, thoracic
aorta, and abdominal aorta). Horizontal lines within the data sets represent means. NS = not
significant.
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Figure 3. Comparison of the Pro-inflammatory Response of Beclin-Het and ATG5-mϕKO
Macrophages
Experiments in (A–C) utilized cultured thioglycollate-elicited peritoneal macrophages.
(A) Western blot analysis of ATG5, p62, Beclin-1, and LC3 expression in macrophages
derived from control vs. ATG5-mϕKO mice.
(B) Macrophages from control vs. ATG5-mϕKO mice treated with LPS (100 ng/ml) for the
indicated times (in hours). Cell culture supernatants were assayed for IL-1β (left panel) and
TNF-α (right panel) concentration by ELISA.
(C) Experiments identical to (B) except using macrophages from control vs. Beclin-Het
mice. Experiments were performed in duplicate.
(D) Cohorts of control and ATG5-mϕKO mice were injected intraperitoneally with LPS (3.5
mg/g) and serum IL-1β at the indicated time points (in hours) was measured by ELISA.
(E) Cohorts of control and ATG5-mϕKO each on the ApoE-null background were fed a
Western diet for 2 months. Serum IL-1β concentration was analyzed by ELISA.
Data are presented as mean ± SEM. *P<0.05 (exact P value shown).
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Figure 4. Quantification of Atherosclerosis in the ATG5-mϕKO Autophagy-Deficient Model
(A) Western blot analysis of p62 and β-actin in whole aorta lysates from control (n=4) and
ATG5-mϕKO (n=4) mice (ApoE-null background) fed a Western diet for 2 months.
Densitometric quantification is shown at right. *P<0.05.
(B, C) Cohorts of control and ATG5-mϕKO mice (ApoE-null background, # of mice shown)
were fed a Western diet for 2 months and atherosclerotic area involvement was determined
by computer image analyses. (B) Oil Red O-stained sections of aortic roots (representative
aortic root sections are shown on the right). (C) En face results for the total aorta and its
regions (aortic arch, thoracic aorta, and abdominal aorta). Horizontal lines within the data
sets represent means. *P<0.05 (exact P value shown), NS = not significant.
(D) Cholesterol efflux to apoAI in AcLDL-loaded control and ATG5-mϕKO peritoneal
macrophages over a 8, 24, and 48 hour time-course. *P<0.05.
(E, F) Cohorts of control and ATG5-mϕKO mice each on the ApoE-null background were
fed a Western diet (E) or a chow diet (F) for 2 months. IL-1β concentration from whole
aorta lysates was analyzed by ELISA.
(G) Western blot analysis of p62 and β-actin in whole aorta lysates from representative
chow diet-fed mice with the densitometric quantification shown below. *P<0.05 (exact P
value shown), NS = not significant.
For all panels, data are presented as mean ± SEM.
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Figure 5. Inflammasomes are Synergistically Activated by Cholesterol Crystals and are
Characteristic of Autophagy-Deficient Macrophages
Experiments in (A–E) utilized cultured thioglycollate-elicited peritoneal macrophages from
control vs. ATG5-mϕKO mice (A–C,E) or ATG7-mϕKO mice (D).
(A) Macrophages were treated with or without LPS (100 ng/ml) for 12 hours. Western blot
analysis of pro-caspase-1 and pro-IL-1β from macrophage cell lysates (top panels) and the
cleaved/activated forms of caspase-1 (p10 subunit) and IL-1β secreted into the cell culture
medium (lower panels) are shown. Densitometric quantification of Western blots from two
separate experiments is shown at right. *P<0.05, NS = not significant.
(B) Macrophages were treated with or without LPS (100 ng/ml) or LPS (100 ng/ml)
+cholesterol-crystals (CC, 500 µg/ml) for the indicated times (in hours). Cell culture
supernatants were assayed for IL-1β concentration by ELISA. Experiments were performed
in duplicate. *P<0.05.
(C) Macrophages were treated with LPS+cholesterol-crystals for 12 hours and ASC
aggregation speck formation was determined by immunofluorescence microscopy. Four
representative merged stains of ASC (red “specks”) and DAPI nuclear stains (blue) are
shown for control and ATG5-mϕKO macrophages. The percentage of cells staining positive
for ASC is quantified on the right.
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(D) Control and ATG7-mϕKO macrophages were treated with LPS and LPS+cholesterol
crystals for 12 hours. Cell culture supernatants were assayed for IL-1β concentration by
ELISA. Experiments were performed in duplicate. *P<0.05.
(E) Macrophages were treated with LPS+cholesterol crystals for 12 hours in the presence or
absence of a caspase-1 inhibitor and cell culture supernatants were assayed for IL-1β
concentration by ELISA. Experiments were performed in duplicate. *P<0.05.
(F) Bone marrow-derived macrophages from wild-type, NLRP3-null, or ASC-null mice
were treated with LPS or LPS+cholesterol crystals for 12 hours and cell culture supernatants
were assayed for IL-1β concentration by ELISA. Experiments were performed in duplicate.
*P<0.05.
For all panels, data are presented as mean ± SEM.
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Figure 6. Increased Cholesterol Crystal Burden and Reactive Oxygen Species in ATG5-mϕKO
Plaques are Potential Mediators of Atherosclerotic Progression
(A) Confocal reflectance microscopy of formaldehyde-fixed frozen-section aortic roots from
cohorts of Western diet-fed control and ATG5-mϕKO (ApoE-null background) mice. Plaque
cholesterol crystal burden was quantified by computer image analysis. Horizontal lines
within the data sets represent means. *P<0.05 (exact P value shown). Reflectance images for
a representative area of the aortic root are shown on the right.
(B) Western blot analysis of p62, ATG5, β-actin, and LC3 expression in wild type
thioglycollate-elicited peritoneal macrophages incubated with cholesterol crystals (500 µg/
ml) for the indicated times (in hours).
(C) Determination of protein oxidation in Western diet-fed control and ATG5-mϕKO
(ApoE-null background) whole aortic lysates using the OxyBlot™ immunoblot detection
assay. Densitometric analysis of control (n=3) and ATG5-mϕKO (n=3) mice is also shown.
*P<0.05.
(D) The use of another oxidative stress marker, Dihydroethidium (DHE)-staining, in
representative aortic root sections of mice. Higher intensity nuclear fluorescence is
indicative of increased superoxide levels.
For all panels, graphical data are presented as mean ± SEM.
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Figure 7. Schematic Depiction of the Links between Autophagy, Inflammasomes, and
Atherosclerotic Progression
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